EHR

CIO Views Recognizes Glytec’s Mission to Improve Diabetes Care; CEO Patrick Cua Named to CIO Views’ “10 Most Innovative CEOs Making a Difference in 2025”

BOSTON, Mass., Sept. 4, 2025 /PRNewswire/ -- Glytec, the leading provider of an AI-powered technology platform for diabetes and related...

Global Working Group Releases Publication on Responsible Use of Artificial Intelligence in Creating Lay Summaries of Clinical Trial Results

New publication underscores the importance of human oversight, transparency, and patient involvement in AI-assisted lay summaries. BOSTON, Sept. 4, 2025...

Global Working Group Releases Publication on Responsible Use of Artificial Intelligence in Creating Lay Summaries of Clinical Trial Results

New publication underscores the importance of human oversight, transparency, and patient involvement in AI-assisted lay summaries. BOSTON, Sept. 4, 2025...

Assort Health Announces Inaugural Assort Ascend Customer Summit to Support Healthcare Leaders in Navigating AI Agent Transformation for Patient Engagement and Provider Operations

Assort Health Announces Inaugural Assort Ascend Customer Summit to Support Healthcare Leaders in Navigating AI Agent Transformation for Patient Engagement and Provider Operations

Walmart and Sam’s Club’s Children’s Miracle Network Campaign Concludes, Raising Over $43 Million for Children’s Miracle Network Hospitals

Campaign Raises Critical Funds to Benefit Children's Miracle Network Hospitals SALT LAKE CITY, Sept. 2, 2025 /PRNewswire/ -- Walmart and...

Abridge Partnership Scales Ambient Clinical Intelligence Across Hartford HealthCare’s Clinical Enterprise

HARTFORD, Conn. & PITTSBURGH--(BUSINESS WIRE)--Abridge’s AI-powered ambient clinical intelligence platform has been selected by Hartford HealthCare, Connecticut’s most comprehensive healthcare...

United States Data Center Construction Market Report 2025-2034 | Hyperscale Growth and Cloud Giants AWS, Google Cloud, and Microsoft Azure Fuel Developments – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "United States Data Center Construction Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering. The...

Boehringer’s HERNEXEOS® approved in China as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC

Illustrative image Laboratory, Boehringer Ingelheim This press release is not intended for UK and US media.  HERNEXEOS® (zongertinib tablets) has been...

Novartis Leqvio® shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain

V-DIFFERENCE is first study to show that Leqvio prioritized after statins helps more patients achieve guideline low-density lipoprotein cholesterol (LDL-C)...

error: Content is protected !!